ME Therapeutics Holdings, Inc. (TSE:METX) has released an update.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
ME Therapeutics Holdings Inc. has appointed Karim Lalji as Chief Business Officer, bringing his extensive experience in driving growth and shareholder value in the life sciences sector. Lalji’s impressive track record includes leading successful product launches and securing major licensing agreements, positioning him as a valuable asset for the company’s future growth.
For further insights into TSE:METX stock, check out TipRanks’ Stock Analysis page.